Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hydroxyurea-induced dermatomyositis-like eruption.

Michael J Dacey1, Jeffrey P Callen

  • 1Division of Dermatology, Department of Medicine, University of Louisville School of Medicine, Kentucky, USA.

Journal of the American Academy of Dermatology
|March 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upadacitinib for recalcitrant extraintestinal Crohn disease.

JAAD case reports·2026
Same author

Characterizing superficial epidermolytic ichthyosis in a patient with KRT2 mutation responsive to ustekinumab.

JAAD case reports·2026
Same author

Generalized bullous fixed drug eruption related to intravenous contrast.

Dermatology online journal·2025
Same author

Evolution of Subacute Cutaneous Lupus Erythematosus.

JAMA dermatology·2025
Same author

Lupus miliaris disseminatus faciei: A unique presentation with extrafacial involvement.

Dermatology online journal·2025
Same author

Erythromelalgia and the Association With Paraproteinemias: A Retrospective Case Series.

International journal of dermatology·2025

Hydroxyurea, a chemotherapy drug for myelodysplasia, can cause skin issues. This case highlights a rare dermatomyositis-like eruption as a potential adverse cutaneous effect of hydroxyurea.

Area of Science:

  • Dermatology
  • Oncology
  • Pharmacology

Background:

  • Hydroxyurea is a cytotoxic chemotherapy agent commonly prescribed for myelodysplastic syndromes.
  • Adverse cutaneous reactions are known side effects of hydroxyurea treatment.
  • These reactions encompass a range of dermatological manifestations.

Observation:

  • This report details a specific case of a patient experiencing a dermatomyositis-like eruption.
  • The eruption was attributed to hydroxyurea therapy.
  • This presentation is a rare but documented adverse effect.

Findings:

  • The case study documents hydroxyurea-induced dermatomyositis-like eruption.
  • Review of existing literature confirms this as a recognized, albeit infrequent, cutaneous side effect.

Related Experiment Videos

  • Other reported hydroxyurea-related skin issues include leg ulcers, hyperpigmentation, and lichen planus-like eruptions.

    • Implications:

    • Increased awareness among clinicians is crucial for early recognition and management of hydroxyurea-induced skin conditions.
    • Dermatomyositis-like eruptions should be considered in patients on hydroxyurea presenting with characteristic symptoms.
    • Prompt identification can guide treatment adjustments and prevent potential complications.